Crizotinib-Associated Toxic Epidermal Necrolysis in an ALK-positive Advanced NSCLC Patient

Molecular and Clinical Oncology - United Kingdom
doi 10.3892/mco.2018.1553
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Spandidos Publications

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy